Trial Details

COMPLETED
Basic Information
Clinical ID c4731
Identifier NCT00055536
Trial Title Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: natalizumab
Participant Information
Sponsor Biogen
City Gainesville
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2002-04
Primary Completion Date 2003-07
Completion Date 2003-07